The vast majority of biotechnology advancements evolve from years of research, either within a University or the research arm of a major biopharmaceutical company, and as such, are provided with substantial budgets for the entire development process.
ProteoNova began as simply an idea. Without University or biopharma backing, ProteoNova called in favors, took on investors, and was able to continue the research. Despite what at times seemed like insurmountable odds, the company has managed to successfully develop the AcPET system. The following historical timeline presents the key events in the development of our technology.